GR-CDXL4 samples also strongly expressed SLFN11 with 70%, 90%, and 90% cell positivity in the CDX, the CDX-derived cell line, and the mouse metastatic tumor, respectively. The gene discussed is SLFN11; the disease is metastatic neoplasm.